Bivalent or Dual-targeting Agents
- Luo, Yang, et al. "Development of [68Ga]Ga/[177Lu] Lu-DOTA-NI-FAPI-04 Containing a Nitroimidazole Moiety as New FAPI Radiotracers with Improved Tumor Uptake and Retention."Journal of Medicinal Chemistry(2025).68,348-360. https://doi.org/10.1021/acs.jmedchem.4c02015
- Zhihao Zha, Karl Ploessl, Seok Rye Choi, Ruiyue Zhao, Wenbin Jin, Ran Wang, David Alexoff, Lin Zhu and Hank F. Kung. "Lu-177-Labeled Hetero-Bivalent Agents Targeting PSMA and Bone Metastases for Radionuclide Therapy". J Med Chem. 2023 66 (17), 12602-12613. https://doi.org/10.1021/acs.jmedchem.3c01294
-
Jin, Wenbin, et al. "PSMA and SSTR2 Dual-Targeting Theranostic Agents for Neuroendocrine-Differentiated Prostate Cancer (NEPC)."Journal of Medicinal Chemistry(2025). https://doi.org/10.1021/acs.jmedchem.4c02768
- Yang Luo,Wenbin Jin,Ran Wang,Ruiyue Zhao,Lin Zhu*,Hank F. Kung*. 68Ga/177Lu-Labeled Bivalent Agents for Targeting Hypoxia and PSMA-Binding in Prostate Cancer. J. Med. Chem. 2024, 67 (15), 13491-13506. https://doi.org/10.1021/acs.jmedchem.4c01420
- Hank Kung, Seok Choi, Karl Ploessl, Zhihao Zha and Zehui Wu. New 68Ga Glu-Urea-Lys(Ahx)-HBED-CC-bisphosponate as a dual-targeted imaging agent for PSMA and bone metastasis.Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1395
